Nanofibrous piezoelectric structures for composite materials to be used in electrical and electronic components

This paper deals with realization of multifunctional composite materials, having piezoelectric effect. First of all polymeric mats of electrospun piezoelectric nanofibers were realized with different geometries. Such effect has been maximized by designing properly the electrospinning apparatus in order to enhance the electric field in the interelectrodic space which polarize the dipolar moments. The mats are then integrated in a silicon rubber matrix and measurements of the electromechanical response of the composite materials thus manufactured are performed. A good integration of nanofibers inside the host material is evidenced by electron microscopy images, allowing delaminations, which could occur using piezoelectric films, to be avoided. A large electrical response to both impact and vibration stimuli has been finally demonstrate

Veterinary Regenerative Medicine for Musculoskeletal Disorders: Can Mesenchymal Stem/Stromal Cells and Their Secretome Be the New Frontier?

Regenerative medicine aims to restore the normal function of diseased or damaged cells, tissues, and organs using a set of different approaches, including cell-based therapies. In the veterinary field, regenerative medicine is strongly related to the use of mesenchymal stromal cells (MSCs), which belong to the body repair system and are defined as multipotent progenitor cells, able to self-replicate and to differentiate into different cell types. This review aims to take stock of what is known about the MSCs and their use in the veterinary medicine focusing on clinical reports on dogs and horses in musculoskeletal diseases, a research field extensively reported in the literature data. Finally, a perspective regarding the use of the secretome and/or extracellular vesicles (EVs) in the veterinary field to replace parental MSCs is provided. The pharmaceuticalization of EVs is wished due to the realization of a Good Manufacturing Practice (GMP product suitable for clinical trials

Nanofibrous piezoelectric structures for composite materials to be used in electrical and electronic components

This paper deals with realization of multifunctional composite materials, having piezoelectric effect. First of all polymeric mats of electrospun piezoelectric nanofibers were realized with different geometries. Such effect has been maximized by designing properly the electrospinning apparatus in order to enhance the electric field in the interelectrodic space which polarize the dipolar moments. The mats are then integrated in a silicon rubber matrix and measurements of the electromechanical response of the composite materials thus manufactured are performed. A good integration of nanofibers inside the host material is evidenced by electron microscopy images, allowing delaminations, which could occur using piezoelectric films, to be avoided. A large electrical response to both impact and vibration stimuli has been finally demonstrated

Hastes florais de cenoura: uma opção para a floricultura.

bitstream/item/33614/1/documento-175.pd

First Report of Meloidogyne arenaria on Lisianthus (Eustoma grandiflorum) in Brazil.

201

Clinical Effects of the Extract of the Seeds of the Indian Celery-Apium Graveolens-In Horses Affected by Chronic Osteoarthritis.

The extract of the seeds from Indian celery, Apium greaveolens (CSE), tested in experimental animals (rodents), and in humans aected by chronic osteoarthritic diseases, exhibits anti-inflammatory eects that can be compared, to some degree, to those of non-steroid anti-inflammatory drugs (NSAID). In view of a potential use of CSE in the equine species, it was tested on horses aected by chronic articular pathologies. The trial was performed on 20 horses divided into three dierent groups, orally treated with 0 (controls), 7.0 or 30 g of CSE BID. Basic orthopedic examinations were conducted, vital signs were observed, and blood samples collected. Improvement was observed at the highest dosage tested (30 g of CSE BID), as reflected in the score values of three clinical parameters, (i) amplitude and (ii) sensitivity to passive flexion and (iii) flexion test. Since the improvement of these parameters can be correlated with a lower perception of the pain, the present data suggest that the CSE treatment can have an analgesic eect in horses aected by chronic osteoarthritic diseases

Platelet-Rich Plasma combined with a sterile 3D polylactic acid scaffold for postoperative management of complete hoof wall resection for keratoma in four horses.

Keratoma is a non-malignant horse tumour that grows in the space between the horn of the hoof and the distal phalanx. Keratoma causes lameness in the horse, and surgical excision is the treatment of choice. Four horses underwent removal of a keratoma by complete hoof wall resection. The remaining wound was treated with Platelet-Rich Plasma (PRP) combined with a sterile 3D polylactic acid scaffold. The PRP was applied at 3, 6, 9, 12, 15 and 18 days postoperatively. The surgical site was cleaned with gauzes and swabs soaked in Ringer’s lactate solution before applying PRP and the foot bandage. Healthy granulation tissue developed at 6-21 days postoperatively. The hoof wall defect was completely filled with new hoof wall within 6-8 months after surgery. All horses returned to their previous exercise level and no recurrence of lameness was reported by the owner

Canine mesenchymal cell lyosecretome production and safety evaluation after allogenic intraarticular injection in osteoarthritic dogs

In recent years, mesenchymal stromal cells (MSCs) have shown promise as a therapy in treating musculoskeletal diseases, and it is currently believed that their therapeutic effect is mainly related to the release of proteins and extracellular vesicles (EVs), known as secretome. In this work, three batches of canine MSC-secretome were prepared by standardized processes according to the current standard ISO9001 and formulated as a freeze-dried powder named Lyosecretome. The final products were char-acterized in protein and lipid content, EV size distribution and tested to ensure the microbiological safety required for intraarticular injection. Lyosecretome induced the proliferation of adipose tissue-derived canine MSCs, tenocytes, and chondrocytes in a dose-dependent manner and showed anti-elastase activ-ity, reaching 85% of inhibitory activity at a 20 mg/mL concentration. Finally, to evaluate the safety of the preparation, three patients affected by bilateral knee or elbow osteoarthritis were treated with two intraarticular injections (t = 0 and t = 40 days) of the allogeneic Lyosecretome (20 mg corresponding 2 × 106 cell equivalents) resuspended in hyaluronic acid in one joint and placebo (mannitol resuspended in hyalu-ronic acid) in the other joint. To establish the safety of the treatment, the follow-up included a questionnaire addressed to the owner and orthopaedic examinations to assess lameness grade, pain score, func-tional disability score and range of motion up to day 80 post-treatment. Overall, the collected data suggest that intra-articular injection of allogeneic Lyosecretome is safe and does not induce a clinically significant local or systemic adverse response

Hibridações, frutificação efetiva e desenvolvimento de frutos de pereira.

A principal finalidade da hibridação é a obtenção de populações segregantes, a partir das quais indivíduos superiores podem ser selecionados. A falta de porta-enxertos adaptados para cultura da pereira no Brasil faz com que técnicas como o melhoramento genético clássico sejam aplicadas. Deste modo, para obtenção e seleção do material adequado a busca por segregação genética é continua, sendo utilizadas como alternativa cultivares copas. Com o objetivo específico de obter uma população segregante, visando à avaliação na frutificação efetiva, quantidade de sementes e massa e diâmetro de frutos oriundos de polinização aberta e dirigida, foram realizados seguintes cruzamentos: T1- Polinização aberta; T2- autopolinização de Willian?s e T3- Willian?s X Santa Maria (doadora de pólen). O delineamento experimental utilizado foi inteiramente casualizado com três repetições de 20 polinizações dirigida por tratamento. A polinização aberta resultou em maior frutificação efetiva. Já massa e diâmetro dos frutos não diferiu entre os tratamentos. A polinização aberta resultou em maior número de sementes, provavelmente devido a presença de abelhas no pomar

Equine mesenchymal stem/stromal cells freeze-dried secretome (Lyosecretome) for the treatment of musculoskeletal diseases: Production process validation and batch release test for clinical use

In the last decades, it has been demonstrated that the regenerative therapeutic efficacy of mesenchymal stromal cells is primarily due to the secretion of soluble factors and extracellular vesicles, collectively known as secretome. In this context, our work described the preparation and characterization of a freeze-dried secretome (Lyosecretome) from adipose tissue-derived mesenchy-mal stromal cells for the therapy of equine musculoskeletal disorder. An intraarticular injectable pharmaceutical powder has been formulated, and the technological process has been validated in an authorized facility for veterinary clinical-use medicinal production. Critical parameters for quality control and batch release have been identified regarding (i) physicochemical properties; (ii) extracellular vesicle morphology, size distribution, and surface biomarker; (iii) protein and lipid content; (iv) requirements for injectable pharmaceutical dosage forms such as sterility, bacterial endotoxin, and Mycoplasma; and (v) in vitro potency tests, as anti-elastase activity and proliferative activity on musculoskeletal cell lines (tenocytes and chondrocytes) and mesenchymal stromal cells. Finally, proteins putatively responsible for the biological effects have been identified by Lyosecretome pro-teomic investigation: IL10RA, MXRA5, RARRES2, and ANXA1 modulate the inflammatory process RARRES2, NOD1, SERPINE1, and SERPINB9 with antibacterial activity. The work provides a proof-of-concept for the manufacturing of clinical-grade equine freeze-dried secretome, and prototypes are now available for safety and efficacy clinical trials in the treatment of equine musculoskeletal diseases